ADAPI 2019 Tamanna Singal vs INADA - Appeal

On 30 September 2019 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 4 year period of ineligibility on the minor weightlifter Tamanna Singal after her sample tested positive for the prohibited substance Metenolone.
Hereafter the Athlete appealed the ADDAPI decision with the Anti-Doping Appeal Panel of India and requested for a reduced sanction.

The Appeal Panel finds that the presence of a prohibited substance had been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.

The Appeal Panel established that the Athlete acknowledged the use of protein drinks and that her coach had administered injections before the competitions while she failed to mention this on the Doping Control Form.

Since there are no grounds for a reduced sanction the Appeal Panel decides on 13 March 2020 to dismiss the Athlete's appeal and to uphold the decision of 30 September 2019.

show »
Type:
pdf

Parameters:

Legal Source
National Decisions
Date:
13 March 2020
Arbitrator
Dang, Naveen
Kohli, Nalin
Puri, Indu
Original Source
India National Anti-Doping Agency (INADA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Minor
Sport/IFs
Weightlifting (IWF) - International Weightlifting Federation
Other organisations
Anti-Doping Appeal Panel of India (ADAPI)
India National Anti-Doping Agency (INADA)
Laboratories
New Delhi, India: National Dope Testing Laboratory
Doping classes
S1. Anabolic Agents
Substances
Metenolone
Medical terms
Treatment
Various
Supplements
Document type
Pdf file
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin